AU2001278628A1 - Crystal structure of dimethylarginine dimethylaminohydrolase and arginine deiminase - Google Patents

Crystal structure of dimethylarginine dimethylaminohydrolase and arginine deiminase

Info

Publication number
AU2001278628A1
AU2001278628A1 AU2001278628A AU7862801A AU2001278628A1 AU 2001278628 A1 AU2001278628 A1 AU 2001278628A1 AU 2001278628 A AU2001278628 A AU 2001278628A AU 7862801 A AU7862801 A AU 7862801A AU 2001278628 A1 AU2001278628 A1 AU 2001278628A1
Authority
AU
Australia
Prior art keywords
crystal structure
arginine deiminase
dimethylarginine dimethylaminohydrolase
dimethylaminohydrolase
dimethylarginine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001278628A
Inventor
James Mitchell Leiper
Mark Mcalister
Neil Mcdonald
Judith Murray-Rust
Patrick John Thompson Vallance
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University College London
Original Assignee
University College London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University College London filed Critical University College London
Publication of AU2001278628A1 publication Critical patent/AU2001278628A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
AU2001278628A 2000-08-18 2001-08-17 Crystal structure of dimethylarginine dimethylaminohydrolase and arginine deiminase Abandoned AU2001278628A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0020449.5A GB0020449D0 (en) 2000-08-18 2000-08-18 Crystal structure
GB0020449.5 2000-08-18
PCT/GB2001/003687 WO2002016615A2 (en) 2000-08-18 2001-08-17 Crystal structure of dimethylarginine dimethylaminohydrolase and arginine deiminase

Publications (1)

Publication Number Publication Date
AU2001278628A1 true AU2001278628A1 (en) 2002-03-04

Family

ID=9897924

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001278628A Abandoned AU2001278628A1 (en) 2000-08-18 2001-08-17 Crystal structure of dimethylarginine dimethylaminohydrolase and arginine deiminase

Country Status (6)

Country Link
US (1) US20050176060A1 (en)
EP (1) EP1356058A2 (en)
JP (1) JP2004507744A (en)
AU (1) AU2001278628A1 (en)
GB (1) GB0020449D0 (en)
WO (1) WO2002016615A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040214264A1 (en) * 2002-04-19 2004-10-28 Veli-Pekka Valkonen Nucleic acid molecule encoding a variant DDAH 1 protein and uses thereof
WO2003102031A1 (en) * 2002-05-31 2003-12-11 Unither Pharma, Inc. Proteins and methods useful for assessing risk of cardiovascular disease
JP2005137361A (en) * 2003-10-17 2005-06-02 Yokohama City Crystal of peptidylarginine deiminase 4 or its variant protein, peptidylarginine deiminase 4 variant protein, and its complex
CN100404682C (en) * 2004-12-27 2008-07-23 中山大学 Amphioxus dimethyl arginine hydrolase AmphiDDAH gene and its application
EP3661543A4 (en) * 2017-07-31 2021-09-22 The Trustees of Indiana University Modified ddah polypeptides comprising a pharmacokinetic enhancing moiety, improved pharmacology and their uses
CN108871187B (en) * 2018-05-11 2020-06-30 中国烟草总公司郑州烟草研究院 Quantitative characterization method for cigarette tobacco curl degree

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4915794B2 (en) * 1971-11-26 1974-04-17
ATE452185T1 (en) * 1999-01-26 2010-01-15 Univ London DIMETHYLARGININE DIMETHYLAMINOHYDROLASES

Also Published As

Publication number Publication date
WO2002016615A2 (en) 2002-02-28
WO2002016615A3 (en) 2003-04-24
EP1356058A2 (en) 2003-10-29
GB0020449D0 (en) 2000-10-11
US20050176060A1 (en) 2005-08-11
JP2004507744A (en) 2004-03-11

Similar Documents

Publication Publication Date Title
GB0124299D0 (en) Crystal structure of enzyme and uses thereof
AU2002360400A1 (en) Construction and use of micro-electrode arrays
AU2002356762A1 (en) 4-arylquinazolines and use thereof as nhe-3 inhibitors
AU2002250591A1 (en) Processor with protected test and debug mode
AU2002320147A1 (en) Microdialysis probes and methods of use
AU2002341641A1 (en) Crystal structure of interleukin-22 and uses thereof
AU2002337913A1 (en) Glycosulfopeptide inhibitors and methods of use thereof
AU2003207824A1 (en) K-type polarizer and preparation thereof
AU2001278628A1 (en) Crystal structure of dimethylarginine dimethylaminohydrolase and arginine deiminase
AU2002345247A1 (en) Crystal structure of beta-site app cleaving enzyme (bace) and use thereof
AU2001244676A1 (en) Gene concerning brassinosteroid-sensitivity of plants and utilization thereof
AU2002342285A1 (en) Securing and handling of mail
AU2003212891A1 (en) K-type polarizer and preparation thereof
AU2001280646A1 (en) Display and method of manufacture
AU2002363938A1 (en) Methods and use of motoneuronotropic factors
AU2003287802A1 (en) Palpometer and methods of use thereof
AU2002352696A1 (en) Cell substrates and methods of use thereof
AU2003222533A1 (en) Proteins with deglycating activities and methods of using same
AU2002233285A1 (en) Interleukin-1 related gene and protein
AU2002356944A1 (en) Amine oxidase stress-related polypeptides and methods of use in plants
AU2001273287A1 (en) Large scale expression and purification of recombinant proteins
AU2003224874A1 (en) INHIBITORS OF SERINE AND METALLO-ss-LACTAMASES
AU2002340437A1 (en) Crystals and structures of yiim proteins
AU2002353146A1 (en) Cell culture system and methods of use
AU2002327184A1 (en) Biophotonic sensors and methods of use thereof